ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2019

Jan 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2019-01-28

Reporting Person: BOESS CARSTEN (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-28	Stock Option (Right to Buy)	$14.56	A	30000	Acquired	2029-01-28	Common Stock (30000)	Direct

Footnotes

F1: This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on January 28, 2020.